DaVita Inc. (NYSE:DVA) Shares Acquired by Nilsine Partners LLC

Nilsine Partners LLC raised its position in shares of DaVita Inc. (NYSE:DVA) by 0.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,160 shares of the company’s stock after purchasing an additional 92 shares during the period. Nilsine Partners LLC’s holdings in DaVita were worth $1,669,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Transcendent Capital Group LLC bought a new stake in shares of DaVita during the third quarter valued at about $25,000. Blue Trust Inc. raised its position in shares of DaVita by 56.4% during the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after buying an additional 119 shares in the last quarter. Quarry LP acquired a new stake in shares of DaVita in the 3rd quarter worth approximately $60,000. Versant Capital Management Inc boosted its holdings in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares in the last quarter. Finally, ORG Wealth Partners LLC acquired a new position in shares of DaVita during the third quarter valued at approximately $97,000. Institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Barclays boosted their price objective on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial upped their price target on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, DaVita currently has an average rating of “Hold” and a consensus price target of $161.80.

DaVita Stock Up 3.1 %

Shares of DaVita stock opened at $175.53 on Tuesday. DaVita Inc. has a 12-month low of $105.82 and a 12-month high of $176.48. The firm has a market capitalization of $14.39 billion, a PE ratio of 18.94, a price-to-earnings-growth ratio of 0.82 and a beta of 0.92. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. The stock’s fifty day moving average is $158.68 and its 200-day moving average is $154.26.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The firm had revenue of $3.26 billion for the quarter, compared to analysts’ expectations of $3.25 billion. During the same period in the prior year, the company posted $2.85 earnings per share. DaVita’s quarterly revenue was up 4.6% compared to the same quarter last year. Equities analysts anticipate that DaVita Inc. will post 9.71 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.